XOMA Corp

NASDAQ: XOMA
Share price (5/3/24): $25.44
Market cap (5/3/24): $296 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

2 XOMA Corp Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Third party tender offer – amended

Third party tender offer – amended

Details of business combination or exchange offer

Shelf registration

Third party tender offer

Ownership Filter

Biotechnology Value Fund L P

News Filter

Adds Economic Interests in Three First-In-Category Assets to Its Royalty and Milestone Portfolio Including XACIATO™ (Clindamycin Phosphate) Vaginal Gel 2%

Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (Tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma

Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements or Exhibits

Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value

Enters Into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Notice of effectiveness